Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01161966 | Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions | PHASE1 | COMPLETED | 26 | — | — | Jan 1, 2005 | Mar 1, 2005 | Jul 14, 2010 | 1 | United States |
| NCT01161979 | Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions | PHASE1 | COMPLETED | 26 | — | — | Jan 1, 2005 | Mar 1, 2005 | Jul 14, 2010 | 1 | United States |
| Arm | Type | Description |
|---|---|---|
| Zonisamide | EXPERIMENTAL | Zonisamide Capsules 100 mg of Dr.Reddy's laboratories Limited |
| Zonegran | ACTIVE_COMPARATOR | Zonegran Capsules 100 mg of EISAI INC |
| Name | Type | Description |
|---|---|---|
| Zonisamide | DRUG | Zonisamide capsules 100 mg |
| Zonegran | DRUG | Zonegran Capsules 100 mg of EISAI INC |
Inclusion Criteria: * Is the individual a healthy, normal adult man or non-child bearing potential woman who volunteers to participate? * Is s/he at least 18 years of age? * Is his/her BMI between 19 and 30, inclusive? * Is s/he considered reliable and capable of understanding his/her responsibilit...